​

Overview

SOFI is a tripartite collaboration among academic, clinical and industry partners to drive the development, translation and commercialisation of oro-facial innovations.

SOFI aims to:

1. Develop oral devices and technologies with a focus on patient-specific implants and digital solutions, particularly for Asian oro-facial conditions and the elderly
2. Drive oro-facial innovation, accelerate clinical translation and commercialisation by co-locating clinicians, surgeons, engineers and scientists within an integrated healthcare setting in Singapore
3. Leverage the synergies of a multidisciplinary, multi-institutional and cross-industrial collaborative network to grow industry R&D investments

Background

The oro-facial complex is an organ system comprising a complex network of muscular, skeletal, vascular, neuronal, sensory, respiratory and secretary tissues. Maintaining proper function or restoring function of the oro-facial complex is very important for quality of life, especially as a person ages.

With the rapidly ageing Singapore population, there is a growing need for innovative and cost-effective restorative, replacement and reconstructive solutions for the oro-facial complex, harnessing the latest advancements in the engineering arena, such as new imaging technologies, 3D printing and novel biomaterials.

Key Research Areas

Core Research Platforms

1. Advanced characterisation and manufacturing
2. Digital technologies
3. Clinical trials
4. Business development

Members

Cl A/Prof Goh Bee Tin (Lead)
Asst Prof Yu Na
Asst Prof Hemant Vijaykumar Unadkat
Dr Song Yi Lin
Dr Lim Wen Yi
Dr Thanuja Darshani Herath
Dr Liu Yuchun
Dr Zayim Razina d/o Seeni Syed